FY24 facilities to e - W2F2 CCR aquatics facility expansion and offices rooms
Ended Awarded Last action
- Contract number
- 75N91024F00022
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,054,209
Award facts
- Opportunity
-
- NCIOSFM240078 Solicitation number
- Contract value 100% obligated
- $1,054,209.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$62,899 | |
| Terminate for Convenience | $0 | |
| Original award | $1,117,108 |
About this award
The National Cancer Institute (NCI) awarded a $1.05M delivery order to Leidos Biomedical Research Inc. on July 8, 2024, for the FY24 Facilities to E-W2F2 Aquatics Facility Expansion and Offices Rooms project. This cost-plus-fixed-fee delivery order is scheduled for completion by February 27, 2026, and will be performed at the Frederick, Maryland location. The contract carries no set-aside designation, reflecting the contractor's competitive capabilities. As a Federally Funded Research and Development Center (FFRDC) contractor for the NCI and National Institutes of Health, Leidos Biomedical Research Inc. provides comprehensive biomedical research and facilities support services, with this award supporting critical infrastructure improvements at the Frederick National Laboratory for Cancer Research.
Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc., a major global technology and engineering solutions provider headquartered in Reston, Virginia. This delivery order falls within Leidos' broader portfolio of NCI contracts focused on research facilities management and infrastructure enhancement. The aquatics facility expansion and office renovation project represents part of the company's ongoing commitment to maintaining and upgrading federal research infrastructure to support the government's biomedical research initiatives. The award aligns with the Administration's Department of Government Efficiency cost efficiency initiative framework noted in the contract documentation.
Quick answers
Who was awarded contract 75N91024F00022?
75N91024F00022 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on July 8, 2024.
How much is contract 75N91024F00022 worth?
The government has obligated $1,054,209 on 75N91024F00022.
Is contract 75N91024F00022 an order under another contract?
Yes. 75N91024F00022 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91024F00022 competed?
The extent of competition for 75N91024F00022 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award